10 (24 марта 2020): 98, doi: 10.3389/fcimb.2020.00098.
62. Arthi Chinna Meyyappan et al., “Effect of Fecal Microbiota Transplant on Symptoms of Psychiatric Disorders: A Systematic Review,” BMC Psychiatry 20, no. 1 (15 июня 2020): 299, doi: 10.1186/s1288802002654-5.
1. Gebriela Leite et al., “The Duodenal Microbiome Is Altered in Small Intestinal Bacterial Overgrowth,” PLoS One 15, no. 7 (июль 2020): e0234906, doi: 10.1371/journal.pone.0234906.
2. Will Takakura and Mark Pimentel, “Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome— An Update,” Frontiers in Psychiatry 11 (июль 2020): 664, doi: 10.3389 /fpsyt.2020.00664.
3. Xin Feng and XiaoQing Li, “The Prevalence of Small Intestinal Bacterial Overgrowth in Diabetes Mellitus: A Systematic Review and Metaanalysis,” Aging (Albany, NY) 14, no. 2 (январь 2022): 975–998, doi: 10.18632/aging.203854.
4. Erika Ruback Bertges and Júlio Maria Fonseca, “Prevalence and Factors Associated with Small Intestinal Bacterial Overgrowth in Patients with Crohn’s Disease: A Retrospective Study at a Referral Center,” Arq Gastrenterol 57, no. 3 (июль – сентябрь 2020): 283–288, doi: 10.1590 /S00042803.202000000-64.
5. Yongbo Zhang et al., “Prevalence of Small Intestinal Bacterial Overgrowth in Multiple Sclerosis: A CaseControl Study from China,” Journal of Neuroimmunology 301 (15 декабря 2016): 83–87, doi: 10.1016/j.jneuroim.2016.11.004.
6. Jeremy Liu Chen Kiow et al., “High Occurrence of Small Intestinal Bacterial Overgrowth in Primary Biliary Cholangitis,” Journal of Neurogastroenterology and Motility 31, no. 11 (ноябрь 2019): e13691, doi: 10.1111/nmo.13691.
7. Beata PolkowskaPruszynska et al., “Small Intestinal Bacterial Overgrowth in Systemic Sclerosis: A Review of the Literature,” Archives of Dermatological Research 311, no. 1 (январь 2019): 1–8, doi: 10.1007/s004030181874-0.
8. Melissa A. Nickles et al., “Alternative Treatment Approaches to Small Intestinal Bacterial Overgrowth: A Systematic Review,” Journal of Alternative and Complementary Medicine 27, no. 2 (февраль 2021): 108–119, doi: 10.1089/acm.2020.0275.
9. Mahnaz Sandoughi et al., “Effects of Dehydroepiandrosterone on Quality of Life in Premenopausal Women with Rheumatoid Arthritis: A Preliminary Randomized Clinical Trial,” International Journal of Rheumatic Diseases 23, no. 12 (декабрь 2020): 1692–1697, doi: 10.1111/1756185X.13975.
10. Jason R. Bobe et al., “Recent Progress in Lyme Disease and Remaining Challenges,” Frontiers in Medicine 8 (18 августа 2021): 666554, doi: 10.3389/fmed.2021.666554.
11. Paul M. Lantos et al., “Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease,” Arthritis Care & Research (Hoboken, NJ) 73, no. 1 (январь 2021): 1–9, doi: 10.1002/acr.24495.
12. Daniel J. Cameron et al., “Evidence Assessments and Guideline Recommendations in Lyme Disease: The Clinical Management of Known Tick Bites, Erythema Migrans Rashes and Persistent Disease,” ILADS, https://www.ilads.org/patientcare/ilads treatmentguidelines/.
13. Michael T. Melia and Paul G. Auwaerter, “Time for a Different Approach to Lyme Disease and LongTerm Symptoms,” The New England Journal of Medicine 374 (31 марта 2016): 1277–1278, doi: 10.1056/NEJMe1502350.
14. Leena Meriläinen et al., “Morphological and Biochemical Features of Borrelia Burgdorferi Pleomorphic Forms,” Microbiology 161, pt. 3 (март 2015): 516–527, doi: 10.1099/mic.0.000027.
15. Peter Kraiczy, “Hide and Seek: How Lyme Disease Spirochetes Overcome Complement Attack,” Frontiers in Immunology 7 (26 сентября 2016): 385, doi: 10.3389/fimmu.2016.00385.
16. Felipe C. Cabello et al., “Borreliella Burgdorferi AntimicrobialTolerant Persistence in Lyme Disease and Posttreatment Lyme Disease Syndromes,” mBio 13, no. 3 (28 июня 2022): e0344021, doi:10.1128/mbio.03440-21.
17. Giuseppe Conte et al., “Mycotoxins in Feed and Food and the Role of Ozone in Their Detoxification and Degradation: An Update,” Toxins (Basel) 12, no. 8 (30 июля 2020): 486, doi: 10.3390/toxins12080486.
18. Maciej Zelechowski et al., “Patterns of Diversity of Fusarium Fungi Contaminating Soybean Grains,” Toxins (Basel) 13, no. 12 (10 декабря 2021): 884, doi: 10.3390/toxins13120884.
19. Michael R. Gray et al., “Mixed Mold Mycotoxicosis: Immunological Changes in Humans Following Exposure in WaterDamaged Buildings,” Archives of Environmental Health 58, no. 7 (1 июля 2003): 410–420, doi: 10.1080/00039896.2003.11879142.
20. Tamara Tuuminen and Kyösti Sakari Rinne, “Severe Sequelae to MoldRelated Illness as Demonstrated in Two Finnish Cohorts,” Frontiers in Immunology 8 (3 апреля 2017): 382, doi: 10.3389/fimmu.2017.00382.
21. Mohamed Bahie AbouDonia, Allan Lieberman, and Luke Curtis, “Neural Autoantibodies in Patients with Neurological Symptoms and Histories of Chemical/Mold Exposures,” Toxicology and Industrial Health 34, no. 1 (январь 2018): 44–53, doi: 10.1177/0748233717733852.
22. Andrew W. Campbell et al., “Neural Autoantibodies and Neurophysiologic Abnormalities in Patients Exposed to Molds in WaterDamaged Buildings,” Archives of Environmental Health 58, no. 8 (7 августа 2010): doi: 10.3200/AEOH.58.8.464474.
23. William J. Rea et al, “Effects of Toxic Exposure to Molds and Mycotoxins in BuildingRelated Illnesses,” Archives of Environmental Health 58, no. 7 (9 декабря 2003): 399–405, doi: 10.1080/00039896.2003.11879140.
24. “Environmental Relative Moldiness Index (ERMI),” Environmental Protection Agency, https://www.epa.gov/airresearch/environmentalrelativemoldinessindexermi.
25. Robert K. Naviaux, “Metabolic Features of the Cell Danger Response,” Mitochondrion 16 (май 2014): 7–17, doi: 10.1016/j.mito.2013.08.006.
26. “Acupuncture: In Depth,” National Center for Complementary and Integrative Health, https://www.nccih.nih.gov/health/acupuncture-in-depth.
27. Jing Wang et al., “Therapeutic Effect and Mechanism of Acupuncture in Autoimmune Diseases,” The American Journal of Chinese Medicine 50, no. 3 (10 марта 2022): 639–652, doi: 10.1142/S0192415X22500252.
28. Daniel E. Furst et al., “Doubleblind, Randomized, Controlled Pilot Study Comparing Classic Ayurvedic Medicine, Methotrexate, and Their Combination in Rheumatoid Arthritis,” Journal of Clinical Rheumatology 17, no. 4 (июнь 2011): 185–192, doi: 10.1097/RHU.0b013e31821c0310.
29. Jie Kie Phang et al., “Complementary and Alternative Medicine for Rheumatic Diseases: A Systematic Review of Randomized Controlled Trials,” Complementary Therapies in Medicine 37 (апрель 2018): 143–157, doi: 10.1016/j.ctim.2018.03.003.
30. Rajkala P. Patil, Panchakshari D. Patil, Anup B. Thakar, “Panchakarma in Autoimmune Pancreatitis: A Singlecase Study,” AYU 40, no. 4 (октябрь – декабрь 2019): 242–246, doi: 10.4103 / ayu.AYU_15_20; Rahul K. Shingadiya et al., “Autoimmune Bullous Skin Disease Managed with Ayurvedic Treatment: A Case Report,” Ancient Science of Life 36, no. 4 (апрель – июнь 2017): 229–233, doi: 10.4103/asl.ASL_91_16.
1. J. Michael Gaziano et al., “Multivitamins in the Prevention of Cancer in Men: The Physicians’ Health Study II Randomized Controlled Trial,” Journal of the American Medical Association 308, no. 18 (14 ноябрЯ 2012): 1871–1880, doi: 10.1001/jama.2012.14641.
2. Muhammad Shahzeb Khan et al., “Dietary Interventions and Nutritional Supplements for Heart Failure: A Systematic Appraisal and Evidence Map,” European Journal of Heart Failure 23, no. 9 (сентябрь 2021): 1468–1476, doi: 10.1002/ejhf.2278.
3. Haseeb Ahsan et al., “Pharmacological Potential of Tocotrienols: A Review,” Nutrition & Metabolism (London) 11, no. 1 (12 ноября 2014): 52, doi: 10.1186/ 17437075-11-52.
4. Donald R. Davis, Melvin D. Epp, and Hugh D. Riordan, “Changes in USDA Food Composition Data for 43 Garden Crops, 1950 to 1999,” Journal of the American College of Nutrition 23, no. 6 (23 декабря 2004): 669–682, doi: 10.1080/07315724.2004.10719409.
5. Jayme L. Workinger, Robert P. Doyle, and Jonathan Bortz, “Challenges in the Diagnosis of Magnesium Status,” Nutrients 10, no. 9 (1 сентября 2018): 1202, doi: 10.3390/nu10091202.
6. Alessandro Sanna et al., “Zinc Status and Autoimmunity: A Systematic Review and MetaAnalysis,” Nutrients 10, no. 1 (11 января 2018): 68, doi: 10.3390/nu10010068.
7. “Micronutrient Inadequacies in the US Population: An Overview,” Oregon State University, https://lpi.oregonstate.edu/mic/micronutrientinadequacies /overview.
8. Workinger, “Challenges in the Diagnosis of Magnesium Status,” 1202.
9. Clementina Sitzia et al., “Intraerythrocytes Magnesium Deficiency Could Reflect Cognitive Impairment Status Due to Vascular Disease: A Pilot Study,” Journal of Translational Medicine 18 (3 декабря 2020): 458, doi: 10.1186/s1296702002645-w.
10. Tomoka Ao, Junichi Kikuta, and Masaru Ishii, “The Effects of Vitamin D on Immune System and Inflammatory Diseases,” Biomolecules 11, no. 11 (3 ноября 2021): 1624, doi: 10.3390/biom11111624.
11. Nipith Charoenngam et al., “Vitamin D and Rheumatic Diseases: A Review of Clinical Evidence,” International Journal of Molecular Sciences 22, no. 19 (1 октября 2021): 10659, doi: 10.3390/ijms221910659.
12. Jill Hahn et al., “Vitamin D and Marine n-3 Fatty Acid Supplementation and Prevention of Autoimmune Disease in the VITAL Randomized Controlled Trial,”